Fitch also forecasts 3.9 percent revenue growth and 1.2 percent EBITDA growth across its ratings portfolio for 2012, with weak organic trends in the utilization of healthcare services and products.
Slightly positive growth despite a weak operating environment will be supported by greater demand growth in emerging markets, new product launches and an active acquisition environment.
Related Articles on Healthcare Trends:
4 Trends in Hospital CFO Compensation
Healthcare Private Equity: Opportunities, Outlook for 2012
7 Points on Cost Containment and the State of Medicaid
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
